Detalhe da pesquisa
1.
Effects of tolvaptan discontinuation in patients with autosomal dominant polycystic kidney disease: a post hoc pooled analysis.
BMC Nephrol
; 24(1): 182, 2023 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37349694
2.
Obesity Among High School Students in the United States: Risk Factors and Their Population Attributable Fraction.
Prev Chronic Dis
; 15: E137, 2018 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30412690
3.
Tolvaptan and Kidney Function Decline in Older Individuals With Autosomal Dominant Polycystic Kidney Disease: A Pooled Analysis of Randomized Clinical Trials and Observational Studies.
Kidney Med
; 5(6): 100639, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37250503
4.
Lipid lowering therapy patterns and the risk of cardiovascular events in the 1-year after acute myocardial infarction in United Arab Emirates.
PLoS One
; 17(9): e0268709, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36054205
5.
Incidence of corneal adverse events in patients with multiple myeloma and their clinical and economic impact: A real-world retrospective cohort study.
J Med Econ
; 25(1): 182-192, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35023807
6.
Geographic variations in lipid-lowering therapy utilization, LDL-C levels, and proportion retrospectively meeting the ACC/AHA very high-risk criteria in a real-world population of patients with major atherosclerotic cardiovascular disease events in the United States.
Am J Prev Cardiol
; 6: 100177, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34327500
7.
Low-density lipoprotein cholesterol lowering in real-world patients treated with evolocumab.
Clin Cardiol
; 44(5): 715-722, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33760276
8.
Patient characteristics and acute cardiovascular event rates among patients with very high-risk and non-very high-risk atherosclerotic cardiovascular disease.
Clin Cardiol
; 44(10): 1457-1466, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34351003
9.
Impact of Lurasidone and Other Antipsychotics on Body Weight: Real-World, Retrospective, Comparative Study of 15,323 Adults with Schizophrenia.
Int J Gen Med
; 14: 4081-4094, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34366678
10.
Tolvaptan and Number Needed to Harm in Autosomal Dominant Polycystic Kidney Disease.
Kidney Med
; 6(4): 100802, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38562967
11.
Demographic And Clinical Characteristics Of Patients Prescribed Proprotein Convertase Subtilisin/kexin Type 9 Inhibitor Therapy And Patients Whose Current Lipid-Lowering Therapy Was Modified.
Ther Clin Risk Manag
; 15: 1325-1332, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-32009789
12.
Confirming the timing of phase-based costing in oncology studies: a case example in advanced melanoma.
J Med Econ
; 21(2): 212-217, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29022427